Clinical Trial Update: A Study of Etoposide-carboplatin in Combination With Pembrolizumab and Lenvatinib Maintenance in HG-NETs [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating etoposide-carboplatin with pembrolizumab and lenvatinib maintenance in high-grade neuroendocrine tumors; status is active…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• High-grade Neuroendocrine Tumor
• Neuroendocrine Tumor

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• Etoposide (Etoposide)
• Lenvatinib (lenvatinib)
• Pembrolizumab (pembrolizumab)

Snippet

Sponsor: Imperial College London | Conditions: Neuroendocrine Tumors | Phase 2 | Status: ACTIVE_NOT_RECRUITING